‘Ebola Could Have Wiped Us All’: Slow Lockdown Haunts Uganda

Vaccines exist to prevent Ebola, but there is no approved vaccine or drug treatment for the Sudan strain of the virus, which caused the recent outbreak in Uganda. A clinical trial of three vaccines — made by the Washington-based Sabin Vaccine Institute, the University of Oxford and the American pharmaceutical company Merck — is being prepared. Researchers have also begun a clinical trial of two monoclonal antibodies donated by the United States that can help boost patients’ chances of survival. […]

Read More… from ‘Ebola Could Have Wiped Us All’: Slow Lockdown Haunts Uganda

Sabin Vaccine Institute Delivers Ebola Sudan Vaccine to Fight Outbreak in Uganda

Sabin Vaccine Institute is the first organization to provide the World Health Organization (WHO) its Ebola Sudan vaccine to help with the Ebola Sudan outbreak in Uganda. Approximately 1,100 doses of Sabin’s vaccine are now in Uganda. Another 8,500 doses will be made available to WHO on a rolling basis through January. The WHO announced last month that Sabin’s Ebola Sudan vaccine would be one of three vaccines included in a planned ring vaccination trial in Uganda, following the recommendation of a WHO-convened independent expert committee. Sabin also plans to supply a further 25,000 doses early next year. There is no approved vaccine for Ebola Sudan yet; the outbreak, which is now waning, began in Uganda in September and to date has killed at least 55 people. […]

Read More… from Sabin Vaccine Institute Delivers Ebola Sudan Vaccine to Fight Outbreak in Uganda